Retatrutide 15 mg

Retatrutide – GLP-1 + GIP Dual Agonist (15mg/3ml Vial)
Take control of your health with Retatrutide, a next-generation peptide designed to target GLP-1 and GIP receptors for enhanced metabolic support. This premium-grade formulation by Viking Pharma is presented in a multi-dose vial (15mg per 3ml), ensuring convenience and consistent quality.